For laboratory research use only. This material is not a drug, is not approved by the FDA for any use, and must not be administered to humans or animals.
Volume pricing applies from 2 vials. Free cold-chain shipping on orders over $150.
Scientific Overview
Retatrutide is an investigational peptide designed to activate the GLP-1, GIP, and glucagon receptors simultaneously. As a triple receptor agonist, it represents an important area of ongoing research in metabolic science.
Mechanism
Retatrutide is studied as a triple agonist at GLP-1, GIP, and glucagon receptors. Multi-receptor activation is investigated for effects on energy expenditure, glucose metabolism, and appetite-related signaling in metabolic research.
Areas of Active Scientific Research
Current research is exploring its effects on metabolic regulation, energy expenditure, appetite signaling, glucose metabolism, and body composition in laboratory models.
Molecular Characteristics
- Molecular weight
- Confirmed on the batch Certificate of Analysis
- Formula
- Confirmed on the batch Certificate of Analysis
- Sequence
- Investigational triple incretin/glucagon receptor agonist peptide
- Appearance
- Lyophilized powder, white to pale solid, research-grade presentation.
- Vial size
- 15mg
- Grade
- Research grade (RUO)
Storage Recommendations
For laboratory research use only. Store lyophilized material at −20°C or below. Reconstitute and handle according to institutional SOPs for peptide research.
Purity
Target purity ≥99% by HPLC. The binding value for any vial is the result on that lot’s Certificate of Analysis.
Batch documentation
Contact support with your order or batch number to request the analytical record for a specific lot, or use COA Verification.
support@primelabs.bioWhat a COA demonstrates
Batch-specific identity verification, purity by validated analytical methods (e.g. HPLC), and third-party laboratory testing records for the referenced lot.
What a COA does not demonstrate
Clinical efficacy, safety for human or veterinary use, or suitability for any application outside qualified laboratory research.
Quality Assurance
Each lot is supported by batch-specific analytical documentation used to verify identity and purity. The Certificate of Analysis is the binding record for that vial.
References
Selected peer-reviewed literature for research context. Prime Labs citations do not constitute therapeutic claims.
- Jastreboff A.M. et al. — Triple-Hormone-Receptor Agonist Retatrutide for Obesity — Phase 2 Trial. New England Journal of Medicine, 2023.